These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 6083916

  • 1. [Determination of factor XII, plasma prekallikrein and factor V in patients with thrombophilic states].
    Stürzebecher J, Huyke R, Vogel G.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):492-6. PubMed ID: 6083916
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Determination of prekallikrein using an amidolytic assay in plasma samples of critically ill patients.
    Kalter ES, Vlooswijk RA, Bouma BN.
    Acta Chir Scand Suppl; 1982; 509():43-7. PubMed ID: 6962618
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [A study of coagulation contact factors in hereditary angioneurotic oedema (author's transl)].
    Soulier JP, Gozin D, Ollier-Hartmann MP, Hartmann L.
    Nouv Presse Med; 1981 May 02; 10(20):1627-31. PubMed ID: 6166918
    [Abstract] [Full Text] [Related]

  • 9. Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa).
    Alving BM, Tankersley DL, Mason BL.
    J Lab Clin Med; 1983 Feb 02; 101(2):226-41. PubMed ID: 6549773
    [Abstract] [Full Text] [Related]

  • 10. Enhanced specificity of immunoblotting using radiolabeled antigen overlay: studies of blood coagulation factor XII and prekallikrein in plasma.
    Lämmle B, Berrettini M, Griffin JH.
    Anal Biochem; 1986 Jul 02; 156(1):118-25. PubMed ID: 3638135
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hageman factor, high molecular weight kininogen, and prekallikrein in chronic liver disease.
    Cordova C, Violi F, Alessandri C, Ferro D, Saliola M, Balsano F.
    J Clin Pathol; 1986 Sep 02; 39(9):1003-5. PubMed ID: 3639088
    [Abstract] [Full Text] [Related]

  • 14. Studies on assays for plasma prekallikrein and for the monitoring of coumarol therapy.
    Egberg N, Bergström K.
    Haemostasis; 1978 Sep 02; 7(2-3):85-91. PubMed ID: 149049
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Plasma contact activation and decrease of factor V activity on negatively-charged polyelectrolytes.
    Boffa MC, Dreyer B, Pusineri C.
    Thromb Haemost; 1984 Feb 28; 51(1):61-4. PubMed ID: 6719390
    [Abstract] [Full Text] [Related]

  • 17. Prekallikrein deficiency in a family of miniature horses.
    Turrentine MA, Sculley PW, Green EM, Johnson GS.
    Am J Vet Res; 1986 Nov 28; 47(11):2464-7. PubMed ID: 3641551
    [Abstract] [Full Text] [Related]

  • 18. [Contact coagulation factors].
    Kojima T, Saito H.
    Rinsho Byori; 1987 Apr 28; Spec No 70():79-87. PubMed ID: 3302400
    [No Abstract] [Full Text] [Related]

  • 19. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB, Sturk A.
    Eur J Clin Chem Clin Biochem; 1997 Jul 28; 35(7):501-16. PubMed ID: 9263726
    [Abstract] [Full Text] [Related]

  • 20. [Studies on plasma prekallikrein assay method with chromogenic substrates (S-2302)].
    Fukuda C, Iijima K, Nakamura K.
    Rinsho Byori; 1983 Feb 28; 31(2):219-22. PubMed ID: 6190027
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.